REGEN BIOPHARMA, INC. Available-for-sale Securities
REGEN BIOPHARMA, INC. (RGBP) had Available-for-sale Securities of $0 as of 2022-09-30, per its 10-Q filed 2023-01-19.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecurities · last filed 2023-01-19
- 2022-09-30: Available-for-sale Securities $0.00.
- 2022-06-30: Available-for-sale Securities $26.83K.
- 2022-03-31: Available-for-sale Securities $67.71K.
- 2021-12-31: Available-for-sale Securities $74.11K.
| Period end | Available-for-sale Securities | Available-for-sale Securities as first filed |
|---|---|---|
| 2022-09-30 | $0.00 10-Q · filed 2023-01-19 | |
| 2022-06-30 | $26.83K 10-Q · filed 2022-07-22 | |
| 2022-03-31 | $67.71K 10-Q · filed 2022-04-21 | |
| 2021-12-31 | $74.11K 10-Q · filed 2022-01-20 | |
| 2021-09-30 | $198.01K 10-K · filed 2022-11-15 | |
| 2021-06-30 | $1.03M 10-Q/A · filed 2021-12-22 | |
| 2021-03-31 | $19.97K 10-Q · filed 2021-08-18 | |
| 2020-12-31 | $19.97K 10-Q · filed 2021-08-13 | |
| 2020-09-30 | $0.00 10-Q/A · filed 2021-12-22 | $19.97K 10-K · filed 2021-08-04 |
| 2020-06-30 | $19.97K 10-Q · filed 2021-08-05 | |
| 2020-03-31 | $19.97K 10-Q · filed 2021-08-05 | |
| 2019-12-31 | $19.97K 10-Q · filed 2021-08-05 | |
| 2019-09-30 | $19.97K 10-Q · filed 2021-08-05 | |
| 2018-09-30 | $166.25K 10-K · filed 2021-06-21 | |
| 2018-06-30 | $468.25K 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $486.65K 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $505.85K 10-Q · filed 2018-02-06 | |
| 2017-09-30 | $465.85K 10-K · filed 2018-12-27 | |
| 2017-06-30 | $395.00K 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $320.00K 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $312.00K 10-Q · filed 2017-01-27 | |
| 2016-09-30 | $112.00K 10-Q · filed 2017-01-27 | |
| 2016-06-30 | $80.00K 10-Q · filed 2016-08-01 | |
| 2016-03-31 | $56.80K 10-Q · filed 2016-04-29 | |
| 2015-12-31 | $120.00K 10-Q · filed 2016-01-28 | |
| 2015-09-30 | $158.40K 10-K · filed 2016-12-21 | |
| 2014-09-30 | $0.00 10-K/A · filed 2017-04-28 |